Clinical Technologies Webinars

  1. How Improving Site Payments Can Make You the Sponsor/CRO of Choice

    In a 2016 CenterWatch survey of 252 global investigative sites, the organization found that "e-clinical technologies are increasing investigative site work burden and performance inefficiencies." With investigative sites under increasing resource constraints, they are becoming far more selective in the companies they choose to do business with.

  2. Can Seniors Use Electronic Clinical Outcome Assessments (eCOA)?

    Is using eCOA as simple as using an ATM machine? In this two-minute video, eCOA subject matter expert and Senior Scientific Advisor, Dr. Jill Platko, addresses how to design an eCOA solution for senior populations. What needs to be considered? Is it different from designing for other populations?

  3. Can Seniors Use eConsent?

    A common myth about electronic informed consent (eConsent) is that senior populations will have trouble using it. CRF Health research proves just the opposite -- in fact, seniors were more likely to adopt and use electronic over paper due to its numerous benefits.

  4. FDA Supports Innovation in Clinical Trials with eConsent

    In this short video, informed consent industry expert, Sandra "SAM" Sather, discusses the Food and Drug Administration's 2016 final guidance document for eConsent, "Use of Electronic Informed Consent."  Learn how the FDA supports Electronic Informed Consent and how it can be used to improve patient compliance and comprehension.

  5. Electronic Informed Consent: 2017 Industry Survey

    Presenters: Naor Chazan, Director of Marketing (but no longer with the company, FYI) and Sandra “SAM” Sather, Quality and Regulatory, TrialConsent) CRF Health's State of eConsent 2017 Report surveyed 100 biotech, pharmaceutical, CRO, and IRB organizations who shared their opinions on Electronic Informed Consent (eConsent). During this webinar, industry expert, Sandra "Sam" Sather, Regulatory and Quality Lead for TrialConsentTM at CRF Health, discusses the results.

  6. Are Local IRBs Really Necessary In Starting Clinical Trials?

    Many researchers have complained that use of different local IRBs to review each research site for a multicenter trial is extremely inefficient and leads to additional cost burdens and trial delays. Despite this, many US research sites have been hesitant to use a single, central IRB. Is there a substantive difference, in terms of efficiency and effectiveness, between reviews conducted by decentralized (local) and centralized IRBs? What are the pros and cons of each? Are local IRBs really even necessary, or do they just create bottlenecks in modern clinical trials? The webinar will focus on these issues and look at study startup metrics associated with IRBs.

  7. eCOA Value: Cost Savings And Beyond

    What if electronic Clinical Outcome Assessments (eCOA) offered advanced functionalities AND it was a less expensive option than paper COA?

  8. Agile Approach to IRT Development

    Bioclinica developed an agile approach to develop their Trident IRT because the traditional approach to developing a system that can manage the increasing complexity of clinical trials is costly, time-consuming and often riddled with errors.

  9. 4 Considerations When Selecting An EDC

    During this webinar, we will examine multiple strategies that make the procedure of finding a better electronic data capture solution less frustrating and more beneficial to your organization.

  10. Social Media In Clinical Trials: Mitigate The Risks, Maximize the Benefits

    Does social media have a place in clinical research? The answer is increasingly "yes!" – but with caveats. Watch now to learn more.